Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.

被引：0
作者：
Petrik, G. G. [1 ]
Pavlishchuk, S. A. [1 ]
机构：
[1] Kuban State Med Univ, Krasnodar, Russia
来源：
CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 02期
关键词：
INSULIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 53
页数：6
相关论文
共 50 条
  • [21] Adverse Effects of Glycemia-Lowering Medications in Type 2 Diabetes
    Razavi-Nematollahi, Laleh
    Ismail-Beigi, Faramarz
    CURRENT DIABETES REPORTS, 2019, 19 (11)
  • [22] Progression of glucose-lowering diabetes therapy in TECOS
    Bethel, M. Angelyn
    Engel, Samuel S.
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Ding, Jie
    Josse, Robert G.
    Alvarsson, Michael
    Hramiak, Irene
    Green, Jennifer B.
    Peterson, Eric D.
    Holman, Rury R.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (01)
  • [23] Use of Glucose-Lowering Agents in Diabetes and CKD
    Alicic, Radica Z.
    Neumiller, Joshua J.
    Galindo, Rodolfo J.
    Tuttle, Katherine R.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (12): : 2589 - 2607
  • [24] THE GLUCOSE-LOWERING THERAPY STRUCTURE IN SPECIAL GROUPS OF TYPE 2 DIABETES MELLITUS PATIENTS BASED ON DATA FROM THE MOSCOW REGION REGISTER
    Misnikova, Inna, V
    Kovaleva, Yulia A.
    Isakov, Mikhail A.
    Dreval, Alexander, V
    DIABETES MELLITUS, 2019, 22 (03): : 206 - 216
  • [25] Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus
    Fauchier, Gregoire
    Bisson, Arnaud
    Bodin, Alexandre
    Herbert, Julien
    Angoulvant, Denis
    Ducluzeau, Pierre Henri
    Lip, Gregory Y. H.
    Fauchier, Laurent
    DIABETOLOGIA, 2021, 64 (11) : 2602 - 2605
  • [26] Insulinization in type 2 diabetes mellitus. Intensification options
    Fuente, Graciela V.
    Sinay, Isaac
    Costa Gil, Jose E.
    Puchulu, Felix
    Dieuzeide, Guillermo
    Rodriguez, Martin
    Faingold, Maria C.
    Litwak, Leon E.
    MEDICINA-BUENOS AIRES, 2016, 76 (03) : 173 - 179
  • [27] Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus
    Gregoire Fauchier
    Arnaud Bisson
    Alexandre Bodin
    Julien Herbert
    Denis Angoulvant
    Pierre Henri Ducluzeau
    Gregory Y. H. Lip
    Laurent Fauchier
    Diabetologia, 2021, 64 : 2602 - 2605
  • [28] Complementary glucagonostatic and insulinotropic effects of DPP-4 inhibitors in the glucose-lowering action in Japanese patients with type 2 diabetes
    Hashimoto K.-I.
    Horikawa Y.
    Takeda J.
    Diabetology International, 2016, 7 (2) : 133 - 140
  • [29] Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Boye, Kristina S.
    Lage, Maureen J.
    Kiljanski, Jacek
    DIABETES THERAPY, 2021, 12 (05) : 1463 - 1474
  • [30] Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk
    Htoo, Phyo T.
    Paik, Julie M.
    Alt, Ethan
    Kim, Dae Hyun
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (12): : 2426 - 2434
12345